These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8133073)

  • 1. A reporter system using a flow cytometer to detect promoter/enhancer activity in lymphoid cell lines.
    Mazda O; Teshigawara K; Fujimoto S; Hattori N; Dou YM; Katsura Y
    J Immunol Methods; 1994 Feb; 169(1):53-61. PubMed ID: 8133073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells.
    Ricksten A; Olsson A; Andersson T; Rymo L
    Nucleic Acids Res; 1988 Sep; 16(17):8391-410. PubMed ID: 2843816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines.
    Nilsson T; Zetterberg H; Wang YC; Rymo L
    J Virol; 2001 Jul; 75(13):5796-811. PubMed ID: 11390581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.
    Schaefer BC; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10565-9. PubMed ID: 7479841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of an Alu-containing, T-cell-specific enhancer located in the last intron of the human CD8 alpha gene.
    Hambor JE; Mennone J; Coon ME; Hanke JH; Kavathas P
    Mol Cell Biol; 1993 Nov; 13(11):7056-70. PubMed ID: 8413295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
    Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
    Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection.
    Woisetschlaeger M; Jin XW; Yandava CN; Furmanski LA; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3942-6. PubMed ID: 1850841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell-specific activation of the Epstein-Barr virus-encoded C promoter compared with the wide-range activation of the W promoter.
    Contreras-Brodin B; Karlsson A; Nilsson T; Rymo L; Klein G
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1159-62. PubMed ID: 8683201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Epstein-Barr virus nuclear antigen-1 in targeted therapy of EBV-associated neoplasia.
    Judde JG; Spangler G; Magrath I; Bhatia K
    Hum Gene Ther; 1996 Mar; 7(5):647-53. PubMed ID: 8845390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells.
    Chang MH; Ng CK; Lin YJ; Liang CL; Chung PJ; ChenML ; Tyan YS; Hsu CY; Shu CH; Chang YS
    DNA Cell Biol; 1997 Jul; 16(7):829-37. PubMed ID: 9260926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extremely efficient gene transfection into lympho-hematopoietic cell lines by Epstein-Barr virus-based vectors.
    Mazda O; Satoh E; Yasutomi K; Imanishi J
    J Immunol Methods; 1997 May; 204(2):143-51. PubMed ID: 9212831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines.
    Yoo L; Speck SH
    J Virol; 2000 Dec; 74(23):11115-20. PubMed ID: 11070007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
    Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 promoter activity in Epstein-Barr virus-transformed B lymphocytes is controlled by nuclear factor-chi B.
    Mouzaki A; Serfling E; Zubler RH
    Eur J Immunol; 1995 Aug; 25(8):2177-82. PubMed ID: 7664781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of the kappa B enhancer of the interleukin-2 receptor alpha chain in somatic cell hybrids is accompanied by the nuclear localization of NF-kappa B.
    Hémar A; Barrand P; Ferrer M; Cornet V; Buttin G; Dautry-Varsat A
    New Biol; 1991 Nov; 3(11):1097-105. PubMed ID: 1777483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.